- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Neoplasm Female in New Zealand
Total 17650 results
-
Hoffmann-La RocheCompletedBreast Cancer | Ovarian Cancer | Prostate CancerUnited States, Korea, Republic of, Italy, Australia, Spain
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
Waikato HospitalWellington HospitalRecruitingGlioblastomaNew Zealand
-
Christian HinrichsNational Cancer Institute (NCI); Cancer Immunology and Metabolism Center of...RecruitingCervical Cancer | Breast Cancer | Gastric Cancer | Lung CancerUnited States
-
ETOP IBCSG Partners FoundationTerminatedBreast CancerItaly, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania
-
Mersana TherapeuticsRecruitingBreast Cancer | Adenoid Cystic Carcinoma | Ovarian Cancer | Fallopian Tube Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Primary Peritoneal Cavity CancerUnited States
-
Proton Collaborative GroupActive, not recruitingBreast Cancer | Breast Neoplasm | Breast Tumor | Cancer of the BreastUnited States
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Endometrial Cancer | Thyroid Cancer | Colorectal Cancer, MelanomaUnited States
-
HiberCell, Inc.Merck Sharp & Dohme LLCCompletedMalignant Neoplasm of BreastUnited States
-
Blueprint Medicines CorporationRecruitingGastric Cancer | Ovarian Cancer | Carcinosarcoma | Advanced Solid Tumors | Endometrial Cancer | Esophageal Adenocarcinoma | HER2-negative Breast Cancer | CCNE1 Amplification | HR+ Breast CancerUnited States, Italy, United Kingdom
-
Telix Pharmaceuticals (Innovations) Pty LtdRecruitingMetastatic Prostate CancerAustralia, New Zealand
-
GenmabTerminatedRenal Cell Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Urothelial CancerUnited States, United Kingdom, Spain
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | HER2-Positive Breast CarcinomaUnited States
-
Stemline Therapeutics, Inc.CompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Genta IncorporatedUnknown
-
Kadmon Corporation, LLCTerminatedHER-2 Positive Breast Cancer | Metastatic Malignant Neoplasm to BrainUnited States
-
NYU Langone HealthRecruitingMLH1 Gene Mutation | RAD51C Gene Mutation | BRIP1 Gene Mutation | MSH6 Gene Mutation | PMS2 Gene Mutation | BRCA-Mutated Ovarian Carcinoma | MSH2 A636P | EPCAMUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedStage IV Lung Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Malignant Female Reproductive System Neoplasm | Stage III... and other conditionsUnited States
-
Haihe Biopharma Co., Ltd.TerminatedBreast Cancer | Ovarian Cancer | Solid Tumor | Prostate Cancer | Endometrial CancerUnited States, Australia, China
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)CompletedBreast Neoplasms | Prostatic Neoplasms | Ovarian NeoplasmsUnited States
-
Personalis Inc.RecruitingMinimal Residual Disease | TNBC - Triple-Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Endometrial CancerUnited States
-
Rutgers, The State University of New JerseyRecruitingBreast Cancer | Colorectal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Prostate Cancer | Endometrial Cancer | Pancreas Cancer | Peritoneal CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research...CompletedBreast CancerCanada, Australia, New Zealand
-
Numab Therapeutics AGTerminatedColorectal Cancer | Fallopian Tube Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Peritoneal Carcinoma | Head and Neck Squamous Cell Carcinoma | Ovarian Carcinoma | Squamous Cell CarcinomaUnited States, Taiwan, Spain
-
BayerCompletedBreast NeoplasmUnited States, Canada
-
Achieve Life SciencesTerminatedBreast NeoplasmUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group BCompletedBreast Cancer | Endometrial CancerUnited States
-
BriaCell Therapeutics CorporationLumaBridgeEnrolling by invitationBreast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Breast Cancer MetastaticUnited States
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Malignant Female Reproductive System NeoplasmUnited States
-
Dana-Farber Cancer InstituteNovartis; AstraZenecaCompleted
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Female Reproductive CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States
-
Eisai Inc.Merck Sharp & Dohme LLCCompleted
-
Proton Collaborative GroupRecruitingBreast Cancer | Breast Neoplasm | Breast Tumor | Cancer of the BreastUnited States
-
Accelerated Community Oncology Research NetworkAventis PharmaceuticalsCompletedBreast NeoplasmUnited States
-
Mundipharma Research LimitedCompletedSoft Tissue Sarcoma | Ovarian Cancer | Endometrial Cancer | Small-cell Lung Cancer | Triple-negative Breast CancerUnited States, Canada
-
Universitaire Ziekenhuizen KU LeuvenUniversity of SydneyCompletedLymphedema | Breast NeoplasmBelgium, Australia
-
Proacta, IncorporatedCompletedUnspecified Adult Solid Tumor, Protocol SpecificNew Zealand
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of
-
Philip SchanerNational Cancer Institute (NCI)TerminatedMelanoma | Head and Neck Neoplasms | Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Breast Neoplasm | Neoplasms, Malignant | Skin NeoplasmUnited States
-
Trans Tasman Radiation Oncology GroupActive, not recruitingBreast CancerAustralia, New Zealand
-
Pharmacyclics LLC.CompletedBreast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Ovarian NeoplasmsUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Breast Neoplasms | Breast AdenocarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic HER2-Negative Breast CarcinomaUnited States
-
University of Auckland, New ZealandCounties Manukau Health; Waikato Hospital; Cancer Trials New ZealandActive, not recruiting
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)TerminatedPain | Breast Cancer | Prostate CancerUnited States, Australia, Peru, Puerto Rico